Perivascular Macrophages Limit Permeability

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 36, Issue 11, 2016, Pages 2203-2212

  He, Huanhuan ^a,e   Mack, Julia J ^b   Güç, Esra ^c   Warren, Carmen M ^b   Squadrito, Mario Leonardo ^c   Kilarski, Witold W ^d   Baer, Caroline ^c   Freshman, Ryan D ^b   McDonald, Austin I ^b   Ziyad, Safiyyah ^b   Swartz, Melody A ^c,d   De Palma, Michele ^c   Iruela Arispe, M Luisa ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c EPFL   (Switzerland)

^d UNIVERSITY OF CHICAGO   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

capillaries; capillary permeability; cell communication; endothelial cells; macrophages

Indexed keywords

ANTIBODY; CLODRONIC ACID; LIPOSOME; VASCULAR ENDOTHELIAL CADHERIN; CADHERIN; DEXTRAN; FLUORESCEIN ISOTHIOCYANATE; LEUKOCYTE ANTIGEN; OVALBUMIN; RHODAMINE; TETRAMETHYLRHODAMINE ISOTHIOCYANATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL PERMEABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DENDRITIC CELL; DISSOCIATION; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PERICYTE; PERITONEUM MACROPHAGE; PERIVASCULAR MACROPHAGE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; ANIMAL; C57BL MOUSE; CAPILLARY; CAPILLARY PERMEABILITY; CELL COMMUNICATION; CELL CULTURE; CELL MOTION; COCULTURE; ENDOTHELIUM CELL; GENETIC TRANSFECTION; HUMAN; MESENTERY; METABOLISM; NUDE MOUSE; PERITONEUM; PHENOTYPE; PHOSPHORYLATION; SKIN; TIME FACTOR; TRANSGENIC MOUSE; VASCULARIZATION;

ANIMALS; ANTIGENS, CD; CADHERINS; CAPILLARIES; CAPILLARY PERMEABILITY; CELL COMMUNICATION; CELL MOVEMENT; CELLS, CULTURED; COCULTURE TECHNIQUES; DEXTRANS; ENDOTHELIAL CELLS; FLUORESCEIN-5-ISOTHIOCYANATE; HUMANS; MACROPHAGES, PERITONEAL; MESENTERY; MICE, INBRED C57BL; MICE, NUDE; MICE, TRANSGENIC; OVALBUMIN; PERITONEUM; PHENOTYPE; PHOSPHORYLATION; RHODAMINES; SKIN; TIME FACTORS; TRANSFECTION;

EID: 84987918430     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.116.307592     Document Type: Article

References (36)

1. Davies LC, Jenkins SJ, Allen JE, Taylor PR. Tissue-resident macrophages. Nat Immunol. 2013; 14: 986-995. doi: 10.1038/ni.2705.
2. Mantovani A, Biswas SK, Galdiero MR, Sica A, Locati M. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol. 2013; 229: 176-185. doi: 10.1002/path.4133.
3. Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol. 2011; 11: 723-737. doi: 10.1038/nri3073.
4. Pollard JW. Trophic macrophages in development and disease. Nat Rev Immunol. 2009; 9: 259-270. doi: 10.1038/nri2528.
5. Baer C, Squadrito ML, Iruela-Arispe ML, De Palma M. Reciprocal interactions between endothelial cells and macrophages in angiogenic vascular niches. Exp Cell Res. 2013; 319: 1626-1634. doi: 10.1016/j. yexcr.2013.03.026.
6. De Palma M, Venneri MA, Roca C, Naldini L. Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat Med. 2003; 9: 789-795. doi: 10.1038/nm871.
7. Giraudo E, Inoue M, Hanahan D. An amino-bisphosphonate targets MMP- 9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. J Clin Invest. 2004; 114: 623-633. doi: 10.1172/JCI22087.
8. De Palma M, Venneri MA, Galli R, Sergi Sergi L, Politi LS, Sampaolesi M, Naldini L. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell. 2005; 8: 211-226. doi: 10.1016/j.ccr.2005.08.002.
9. Lin EY, Li JF, Gnatovskiy L, Deng Y, Zhu L, Grzesik DA, Qian H, Xue XN, Pollard JW. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res. 2006; 66: 11238-11246. doi: 10.1158/0008-5472.CAN-06-1278.
10. Jetten N, Verbruggen S, Gijbels MJ, Post MJ, De Winther MP, Donners MM. Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo. Angiogenesis. 2014; 17: 109-118. doi: 10.1007/s10456-013-9381-6.
11. Fantin A, Vieira JM, Gestri G, Denti L, Schwarz Q, Prykhozhij S, Peri F, Wilson SW, Ruhrberg C. Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. Blood. 2010; 116: 829-840. doi: 10.1182/ blood-2009-12-257832.
12. Outtz HH, Tattersall IW, Kofler NM, Steinbach N, Kitajewski J. Notch1 controls macrophage recruitment and Notch signaling is activated at sites of endothelial cell anastomosis during retinal angiogenesis in mice. Blood. 2011; 118: 3436-3439. doi: 10.1182/blood-2010-12-327015.
13. Das A, Sinha M, Datta S, Abas M, Chaffee S, Sen CK, Roy S. Monocyte and macrophage plasticity in tissue repair and regeneration. Am J Pathol. 2015; 185: 2596-2606. doi: 10.1016/j.ajpath.2015.06.001.
14. Okabe Y, Medzhitov R. Tissue-specific signals control reversible program of localization and functional polarization of macrophages. Cell. 2014; 157: 832-844. doi: 10.1016/j.cell.2014.04.016.
15. Rosas M, Davies LC, Giles PJ, Liao CT, Kharfan B, Stone TC, O'Donnell VB, Fraser DJ, Jones SA, Taylor PR. The transcription factor Gata6 links tissue macrophage phenotype and proliferative renewal. Science. 2014; 344: 645-648. doi: 10.1126/science.1251414.
16. Gosselin D, Link VM, Romanoski CE, Fonseca GJ, Eichenfield DZ, Spann NJ, Stender JD, Chun HB, Garner H, Geissmann F, Glass CK. Environment drives selection and function of enhancers controlling tissuespecific macrophage identities. Cell. 2014; 159: 1327-1340. doi: 10.1016/j. cell.2014.11.023.
17. Lavin Y, Winter D, Blecher-Gonen R, David E, Keren-Shaul H, Merad M, Jung S, Amit I. Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. Cell. 2014; 159: 1312-1326. doi: 10.1016/j.cell.2014.11.018.
18. Okabe Y, Medzhitov R. Tissue biology perspective on macrophages. Nat Immunol. 2016; 17: 9-17. doi: 10.1038/ni.3320.
19. He H, Xu J, Warren CM, Duan D, Li X, Wu L, Iruela-Arispe ML. Endothelial cells provide an instructive niche for the differentiation and functional polarization of M2-like macrophages. Blood. 2012; 120: 3152-3162. doi: 10.1182/blood-2012-04-422758.
20. Hanna RN, Cekic C, Sag D, et al. Patrolling monocytes control tumor metastasis to the lung. Science. 2015; 350: 985-990. doi: 10.1126/science. aac9407.
21. Armulik A, Genové G, Betsholtz C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell. 2011; 21: 193-215. doi: 10.1016/j.devcel.2011.07.001.
22. Brown LF, Guidi AJ, Tognazzi K, Dvorak HF. Vascular permeability factor/vascular endothelial growth factor and vascular stroma formation in neoplasia. Insights from in situ hybridization studies. J Histochem Cytochem. 1998; 46: 569-575.
23. Svensjö E, Cyrino F, Michoud E, Ruggiero D, Bouskela E, Wiernsperger N. Vascular permeability increase as induced by histamine or bradykinin is enhanced by advanced glycation endproducts (AGEs). J Diabetes Complications. 1999; 13: 187-190.
24. Ries CH, Cannarile MA, Hoves S, et al. Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy. Cancer Cell. 2014; 25: 846-859. doi: 10.1016/j.ccr.2014.05.016.
25. Bell RD, Winkler EA, Sagare AP, Singh I, LaRue B, Deane R, Zlokovic BV. Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron. 2010; 68: 409-427. doi: 10.1016/j.neuron.2010.09.043.
26. Armulik A, Genové G, Mäe M, Nisancioglu MH, Wallgard E, Niaudet C, He L, Norlin J, Lindblom P, Strittmatter K, Johansson BR, Betsholtz C. Pericytes regulate the blood-brain barrier. Nature. 2010; 468: 557-561. doi: 10.1038/nature09522.
27. Daneman R, Zhou L, Kebede AA, Barres BA. Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature. 2010; 468: 562-566. doi: 10.1038/nature09513.
28. Kim JH, Kim JH, Yu YS, Kim DH, Kim KW. Recruitment of pericytes and astrocytes is closely related to the formation of tight junction in developing retinal vessels. J Neurosci Res. 2009; 87: 653-659. doi: 10.1002/jnr.21884.
29. Moughon DL, He H, Schokrpur S, Jiang ZK, Yaqoob M, David J, Lin C, Iruela-Arispe ML, Dorigo O, Wu L. Macrophage blockade using CSF1R inhibitors reverses the vascular leakage underlying malignant ascites in late-stage epithelial ovarian cancer. Cancer Res. 2015; 75: 4742-4752. doi: 10.1158/0008-5472.CAN-14-3373.
30. Harney AS, Arwert EN, Entenberg D, Wang Y, Guo P, Qian BZ, Oktay MH, Pollard JW, Jones JG, Condeelis JS. Real-time imaging reveals local, transient vascular permeability, and tumor cell intravasation stimulated by TIE2hi macrophage-derived VEGFA. Cancer Discov. 2015; 5: 932-943. doi: 10.1158/2159-8290.CD-15-0012.
31. Gomez Perdiguero E, Klapproth K, Schulz C, Busch K, Azzoni E, Crozet L, Garner H, Trouillet C, de Bruijn MF, Geissmann F, Rodewald HR. Tissueresident macrophages originate from yolk-sac-derived erythro-myeloid progenitors. Nature. 2015; 518: 547-551. doi: 10.1038/nature13989.
32. Brahmi M, Vinceneux A, Cassier PA. Current systemic treatment options for tenosynovial giant cell tumor/pigmented villonodular synovitis: targeting the CSF1/CSF1R axis. Curr Treat Options Oncol. 2016; 17: 10. doi: 10.1007/s11864-015-0385-x.
33. Tap WD, Wainberg ZA, Anthony SP, et al. Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor. N Engl J Med. 2015; 373: 428-437. doi: 10.1056/NEJMoa1411366.
34. Cassier PA, Italiano A, Gomez-Roca CA, et al. CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study. Lancet Oncol. 2015; 16: 949-956. doi: 10.1016/S1470-2045(15)00132-1.
35. Al-Roubaie S, Hughes JH, Filla MB, Lansford R, Lehoux S, Jones EA. Time-lapse microscopy of macrophages during embryonic vascular development. Dev Dyn. 2012; 241: 1423-1431. doi: 10.1002/dvdy.23835.
36. Gray C, Loynes CA, Whyte MK, Crossman DC, Renshaw SA, Chico TJ. Simultaneous intravital imaging of macrophage and neutrophil behaviour during inflammation using a novel transgenic zebrafish. Thromb Haemost. 2011; 105: 811-819. doi: 10.1160/TH10-08-0525.